Stock SYRE SPYRE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Spyre Therapeutics, Inc.

Equities

SYRE

US00773J2024

Real-time Estimate Cboe BZX
Other stock markets
 11:02:22 2024-05-15 am EDT 		5-day change 1st Jan Change
37.81 USD -3.77% Intraday chart for Spyre Therapeutics, Inc. +14.35% +75.46%
May. 13 Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating MT
May. 09 Spyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SPYRE THERAPEUTICS, INC.
Bio Therapeutic Drugs
-3.89%+14.35%+75.46%+948.89%-77.89% 1.58B
Bullish
Bullish
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. SYRE Stock
  4. Charts Spyre Therapeutics, Inc.
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW